Showing 1 - 10 of 356,103
competition after entry. However, less attention has been paid to pricing behavior in anticipation of brand-to-brand competition … manufacturers under tiered-insurance anticipating branded competition. Our model predicts rising prices for incumbent drugs for a …
Persistent link: https://www.econbiz.de/10012925274
competition after entry. However, less attention has been paid to pricing behavior in anticipation of brand-to-brand competition … manufacturers under tiered-insurance anticipating branded competition. Our model predicts rising prices for incumbent drugs for a …
Persistent link: https://www.econbiz.de/10012453327
Persistent link: https://www.econbiz.de/10014232582
Persistent link: https://www.econbiz.de/10015077056
Persistent link: https://www.econbiz.de/10010345585
Persistent link: https://www.econbiz.de/10012253820
Persistent link: https://www.econbiz.de/10012013562
Persistent link: https://www.econbiz.de/10014234422
We study cartels that operated in the US generic drug industry, leveraging quarterly Medicaid data from 2011-2018 and a difference-in-differences approach comparing the evolution of prices of allegedly collusive drugs with a group of competitive control drugs. Our analysis highlights (i) the...
Persistent link: https://www.econbiz.de/10012670921
Persistent link: https://www.econbiz.de/10011317852